Seer (SEER) Income from Non-Controlling Interests (2020 - 2022)
Seer (SEER) posted quarterly Income from Non-Controlling Interests of $420000.0 for Q3 2022, up 1515.38% year-over-year from $26000.0 in Q3 2021, and up 147.4% quarter-over-quarter from -$886000.0 in Q2 2022.
Seer (SEER) Income from Non-Controlling Interests (2020 - 2022) Analysis & Trends
Seer's Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at $420000.0 for Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 63.60 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 420,000.00 |
| Jun 30, 2022 | -886,000.00 |
| Mar 31, 2022 | -1.69 Mn |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | -62,000.00 |
| Mar 31, 2021 | -26,000.00 |
| Sep 30, 2020 | -159,000.00 |
| Jun 30, 2020 | -255,000.00 |
| Mar 31, 2020 | 533,000.00 |